CRISPR-Cas9 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-05547
Key Product Details
Species Reactivity
Bacteria
Applications
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Chicken IgY
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
C-terminal region of S. aureus CRISPR-Cas9 expressed in and purified from E. coli.
Clonality
Polyclonal
Host
Chicken
Isotype
IgY
Theoretical MW
124 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Description
Stable at 4C for at least one year. Mix 1:1 with 100% glycerol and store at -20C for longer term storage
Scientific Data Images for CRISPR-Cas9 Antibody
Western Blot: CRISPR-Cas9 Antibody [NBP3-05547]
Western Blot: CRISPR-Cas9 Antibody [NBP3-05547] - Western blot analysis of HEK293 cell lysates using chicken pAb to CRISPR-Cas9 [1] protein standard (red), [2] non-transfected cells and [3] transfected cells with GFP-CRISPR-Cas9 (C-terminal 803-1053 amino acids of CRISPR-Cas9) fusion construct. The band at about 53kDa corresponds to the GFP-CAS9 fusion protein.Immunocytochemistry/ Immunofluorescence: CRISPR-Cas9 Antibody [NBP3-05547]
Immunocytochemistry/Immunofluorescence: CRISPR-Cas9 Antibody [NBP3-05547] - HEK293 cells were transfected with a construct including the N-terminal 608 amino acids of S. aureus CRISPR-Cas9 fused to GFP and stained with CRISPR-Cas9 Antibody in red. Transfected cells express the green fusion protein and bind the antibody in red, producing a yellow signal. Nuclear DNA in transfected and non-transfected cells is revealed with the blue DNA stain DAPI.Applications for CRISPR-Cas9 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
1:1000-1:5000
Immunohistochemistry
1:1000-1:5000
Western Blot
1:1000
Formulation, Preparation, and Storage
Purification
IgY purified
Formulation
Supplied as concentrated total IgY preparation from egg yolk. Exact concentration of target specific IgY is not quantifiable as the preparation contains both immune IgY specific for the target and also irrelevant, non-immune IgY.
Preservative
0.035% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. For extended storage, add an equal volume of glycerol, aliquot and store at -20C or below. Avoid repeated freeze-thaw cycles.
Background: CRISPR-Cas9
Using CRISPR-Cas9 technology, double-stranded DNA breaks may be induced within specific targeted genome sequences (target DNA; protospacer) for insertion or removal of DNA sequences for gene editing applications. To target a specific loci, a gRNA that will bind to a specific target sequence of DNA within a genome is created. The gRNA will recognize the DNA sequence, and the Cas9 enzyme will cleave the DNA at the targeted location. Once the targeted DNA is removed by Cas9, the cell's own DNA repair mechanism is used to insert or remove a DNA sequence for genomic editing.
Cas9 detection is used to confirm and evaluate CRISPR Cas9 gRNA transfection efficiency. Western blot analysis of CRISPR-Cas9 gRNA transfected cell lysates with Cas9 antibodies identifies the protein having a theoretical molecular weight of 160kDa. Broad areas of research are benefiting from CRISPR-Cas9 based gene editing tools including studies of basic immunity functions, genetic screening and disease treatment (2). Ethical concerns have led to many countries making it illegal to manipulate human germline cells or perform embryo genome editing.
References
1. Oakes, B. L., Fellmann, C., Rishi, H., Taylor, K. L., Ren, S. M., Nadler, D. C., . . . Savage, D. F. (2019). CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification. Cell, 176(1-2), 254-267.e216. doi:10.1016/j.cell.2018.11.052
2. Chiou, S. H., Winters, I. P., Wang, J., Naranjo, S., Dudgeon, C., Tamburini, F. B., . . . Winslow, M. M. (2015). Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing. Genes Dev, 29(14), 1576-1585. doi:10.1101/gad.264861.115
Long Name
CRISPR-associated Protein 9
Alternate Names
Cas9, CRISPR-associated endonuclease Cas9/Csn1, CRISPR-Cas9/Csn1, CRISPR/Cas9, csn1, SPy_1046, SPy1046, SpyCas9
Additional CRISPR-Cas9 Products
Product Specific Notices for CRISPR-Cas9 Antibody
Chicken products cannot be exported to Canada.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...